Dr. Krajewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bristol Myers Squibb
5 Giralda Farms
Madison, NJ 07940Phone+1 202-321-4531
Summary
- Dr. Krajewski joined BMS as a clinical trial physician in the Nivo heme group. She has served as the clinical director of peds BMT at Westchester Med Center and was a peds BMT attending at HackensackUMC. She received her MD from Chicago Medical School in 2003, completed pediatric residency at Children's National in 2006, and completed fellowship in peds heme/onc at Columbia University in 2006.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2006 - 2009
- Children's National HospitalResidency, Pediatrics, 2003 - 2006
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003
- University of MichiganB.S., Biology & Biopsychology, Magna Cum Laude, 1995 - 1999
Certifications & Licensure
- NJ State Medical License 2010 - 2025
- NY State Medical License 2006 - 2023
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Merit Award American Society of Clinical Oncology (ASCO), 2011
- Attending of the Year Hackensack University Medical Center, 2011
- Best Translational Research Project Columbia University, 2009
- Join now to see all
Clinical Trials
- Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
- Abatacept as GVHD Prophylaxis Phase 2 Start of enrollment: 2013 Feb 01
- Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsSARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report.Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano
Journal for Immunotherapy of Cancer. 2023-01-01 - 2 citationsHematopoietic stem cell transplant in two pediatric patients testing positive for SARS-CoV-2: A case report.Jennifer Krajewski, Jing Chen, Juhi Motiani, Aryeh Baer, Burton Appel
Pediatric Transplantation. 2021-10-27 - 4 citationsThe safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transpla...Jessica Hochberg, Stacey Zahler, Mark B. Geyer, Nan Chen, Jennifer Krajewski
Bone Marrow Transplantation. 2019-02-01
Journal Articles
- The Safety and Efficacy of Clofarabine in Combination with High-Dose Cytarabine and Total Body Irradiation Myeloablative Conditioning and Allogeneic Stem Cell Transpla...Stacey Zahler, Mitchell S Cairo, Jennifer Krajewski, M Fevzi Ozkaynak, Alexandra C Cheerva, Theodore B Moore, Alfred P Gillio, Mark C Walters, Nature
- Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell diseaseEnder KL, Krajewski JA, Babineau J, Tregallo M, Schechter W, Saroyan JM, Kharbanda A, Pediatr Blood Cancer, 1/19/2013
- Pulmonary Thromboembolism in a Child with Sickle Cell Hemoglobin D Disease in the Setting of Acute Chest SyndromeHazel Villanueva, Sandeepkumar Kuril, Jennifer Krajewski, and Aziza Sedrak, Case Reports in Pediatrics, 1/1/2013
- Join now to see all
Abstracts/Posters
- Low Day 100 Transplant-Related Mortality (TRM) and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogeneic Stem Cell T...Krajewski J, Radhakrishnan K, Chen N, Ricci A, Geyer M, Harrison L, Ozkaynak MF, Satwani P, Cheerva A, Talano J, Moore T, Gillio AP, Baxter-Lowe LA, Cairo MS, Tandem annual meeting, 1/1/2013
- Improvement in Acute Management of Vaso-occlusive Pain in Pediatric Sickle Cell Disease with Use of a Clinical PathwayEnder K, Freed J, Babineau J, Tresgallo M, Schechter W, Saroyan J, Kharbanda A, American Society of Hematology annual meeting, 1/1/2010
- Acute Management of Vaso-Occlusive Pain in Pediatric Sickle Cell DiseaseFreed J, Ender, K, American Society of Pediatric Hematology/Oncology annual meeting, 1/1/2009
- Join now to see all
Committees
- Committee Co-chair, STAR Advoacacy/Outreach/Education Committee 2016 - 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: